Health Care Services

Basel Medical

Basel Medical released FY2025 Q3 earnings on November 18 (EST), actual revenue USD 2.633 M, actual EPS USD -0.2057

Basel Medical released FY2025 Annual Earnings on November 18 Post-Market (EST), actual revenue USD 9.219 M, actual EPS USD -0.4899

Basel Medical released FY2025 9 Months Earnings on November 18 (EST), actual revenue USD 6.454 M, actual EPS USD -0.2205

Basel Medical released FY2025 Q4 earnings on November 18 (EST), actual revenue USD 2.768 M, actual EPS USD -0.2162

Basel Medical Group Modifies Underwriting Agreement Terms

Basel Medical released FY2025 Q2 earnings on June 18, 2025 (EST) with actual revenue of USD 1.852M and EPS of USD -0.0071

Basel Medical released FY2025 Q1 earnings on June 18, 2025 (EST) with actual revenue of USD 1.969 M and EPS of USD -0.0076

Basel Medical released FY2025 Semi-Annual earnings on June 18 (EST), actual revenue USD 3.813 M, actual EPS USD -0.0147

Basel Medical Shares Fall Sharply After Technical Signal-Driven Rise

Basel Medical Group Reaffirms Financial Position and Growth Strategy

Wall Street Zen downgrades Basel Medical Group stock rating

Basel Medical Subsidiary Signs a 375 Million Singapore Dollar Medical Product Supply Contract

Basel Medical Group Buys 10,000 Bitcoins for $1 Billion

Basel Medical Subsidiary Signs SGD 375 Million Healthcare Product Supply Contract

Basel Healthcare Group plans to acquire $1 billion worth of Bitcoin via equity swap

Basel Medical Completes Acquisition of Bethesda Medical

Management Changes at Basel Medical Group Ltd

Basel Medical released FY2024 earnings on November 4 (EST), actual revenue USD 7.75 M, actual EPS USD 0.0947

Basel Medical released FY2024 Q4 earnings on November 4, 2024 (EST), with actual revenue of USD 1.971 M and EPS of USD 0.0169

Basel Medical released FY2024 9 Months Earnings on November 4, 2024 (EST) with actual revenue of USD 5.778M and EPS of USD 0.0778

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Cigna

BrightSpring Health Services - Unit

Labcorp

Quest Diagnostics

Hims & Hers Health

BrightSpring Health Services

Chemed

Option Care Health

GeneDx

CorVel

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap